Leitlinie
Review of European guidelines for economic evaluation of medical technologies and pharmaceuticals
HEPAC Health Economics in Prevention and Care · 2000
DOI: 10.1007/s101980050002 ↗Kurz gefasst
Leitlinie in der Zeitschrift HEPAC Health Economics in Prevention and Care, 2000. Verfasst von J.-M. Graf von der Schulenburg und 1 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schulenburg, J. G. V. D., & Hoffmann, C. (2000). Review of European guidelines for economic evaluation of medical technologies and pharmaceuticals. HEPAC Health Economics in Prevention and Care. https://doi.org/10.1007/s101980050002
Vancouver
Schulenburg JGVD, Hoffmann C. Review of European guidelines for economic evaluation of medical technologies and pharmaceuticals. HEPAC Health Economics in Prevention and Care. 2000. doi:10.1007/s101980050002
BibTeX
@article{Schulenburg2000,
author = {Schulenburg, J.-M. Graf von der and Hoffmann, C.},
title = {Review of European guidelines for economic evaluation of medical technologies and pharmaceuticals},
journal = {HEPAC Health Economics in Prevention and Care},
year = {2000},
doi = {10.1007/s101980050002}
}
EUVIMED